Drug Type Small molecule drug |
Synonyms Opa1 inhibitor 0 |
Target |
Action inhibitors |
Mechanism OPA1 inhibitors(OPA1 mitochondrial dynamin like GTPase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Acute Myeloid Leukemia | Preclinical | United States | 15 Oct 2025 |





